UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Physical Therapy in Pediatric and Young Adult Patients With Sickle Cell Disease: Assessing Potential Benefits and Barriers

Journal of pediatric hematology/oncology, 2020-11, Vol.42 (8), p.463-466

2020

Volltextzugriff (PDF)

Direct CNS administration of rituximab and epratuzumab in a pediatric patient with relapsed refractory CNS B‐cell acute lymphoblastic leukemia

Pediatric blood & cancer, 2022-06, Vol.69 (6), p.e29664-n/a

2022

Volltextzugriff (PDF)

Preventing transfusion-transmitted babesiosis: preliminary experience of the first laboratory-based blood donor screening program

Transfusion (Philadelphia, Pa.), 2012-07, Vol.52 (7), p.1523-1529

2012

Volltextzugriff (PDF)

Heterogeneity of the long-term economic burden of severe sickle cell disease: a 5-year longitudinal analysis

Journal of medical economics, 2022-12, Vol.25 (1), p.1140-1148

2022

Volltextzugriff (PDF)

Lovo-cel (bb1111) Gene Therapy for Sickle Cell Disease: Updated Clinical Results and Investigations into Two Cases of Anemia from Group C of the Phase 1/2 HGB-206 Study

Blood, 2022-11, Vol.140 (Supplement 1), p.26-28

2022

Volltextzugriff (PDF)

The Grndad Registry: Contemporary Natural History Data and an Analysis of Real-World Patterns of Use and Limitations of Disease Modifying Therapy in Adults with SCD

Blood, 2020-11, Vol.136 (Supplement 1), p.34-36

2020

Volltextzugriff (PDF)

Efficacy, Safety, and Health-Related Quality of Life (HRQOL) in Patients with Sickle Cell Disease (SCD) Who Have Received Lovotibeglogene Autotemcel (Lovo-cel) Gene Therapy: Up to 60 Months of Follow-up

Blood, 2023-11, Vol.142 (Supplement 1), p.1051-1051

2023

Volltextzugriff (PDF)

Severe Acute Complications of Sickle Cell Disease in Two Expert Referral Centers (UK and Italy): Natural History Studies Highlight Ongoing Unmet Need for Effective Disease Modifying or Curative Therapies

Blood, 2021-11, Vol.138 (Supplement 1), p.3093-3093

2021

Volltextzugriff (PDF)

Refractory cytopenias secondary to copper deficiency in children receiving exclusive jejunal nutrition

Pediatric blood & cancer, 2017-11, Vol.64 (11), p.n/a

2017

Volltextzugriff (PDF)

Weight status of children with sickle cell disease

Pediatrics (Evanston), 2013-04, Vol.131 (4), p.e1168-e1173

2013

Volltextzugriff (PDF)

Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States

PharmacoEconomics, 2024-06, Vol.42 (6), p.693-714

2024

Volltextzugriff (PDF)

Real-World Clinical Burden of Sickle Cell Disease in the US Community-Practice Setting: A Single-Center Experience from the Foundation for Sickle Cell Disease Research

Blood, 2019-11, Vol.134 (Supplement_1), p.5856-5856

2019

Volltextzugriff (PDF)

Predictors of Biologic Efficacy with Lovotibeglogene Autotemcel (Lovo-cel) Gene Therapy in Patients with Sickle Cell Disease

Transplantation and cellular therapy, 2024-02, Vol.30 (2), p.S231-S232

2024

Volltextzugriff (PDF)

Two cases of humoral hypercalcemia of malignancy complicating infantile fibrosarcoma

Pediatric blood & cancer, 2017-10, Vol.64 (10), p.n/a

2017

Volltextzugriff (PDF)

Transfusion-acquired Trypanosoma cruzi infection

Transfusion (Philadelphia, Pa.), 2007-03, Vol.47 (3), p.540-544

2007

Volltextzugriff (PDF)

Lovo-cel (bb1111) Gene Therapy for Sickle Cell Disease (SCD): Updated Group C Clinical Results and Investigations into Two Cases of Anemia from the Phase 1/2 HGB-206 Study

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S288-S289

2023

Volltextzugriff (PDF)

381 - Lovo-cel (bb1111) Gene Therapy for Sickle Cell Disease (SCD): Updated Group C Clinical Results and Investigations into Two Cases of Anemia from the Phase 1/2 HGB-206 Study

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S288-S289

2023

Volltextzugriff (PDF)

Efficacy and Safety in Patients (Pts) with Sickle Cell Disease (SCD) Who Have Received Lovotibeglogene Autotemcel (Lovo-cel) Gene Therapy: Up to 60 Months of Follow-up

Transplantation and cellular therapy, 2024-02, Vol.30 (2), p.S230-S231

2024

Volltextzugriff (PDF)

Prevalence and Complications of Obesity in Sickle Cell Disease

Blood, 2008-11, Vol.112 (11), p.1434-1434

2008

Volltextzugriff (PDF)

Multilineage Engraftment with Minimal Graft-Versus-Host Disease Following In Utero Transplantation of S-59 Psoralen/Ultraviolet A Light-Treated, Sensitized T Cells and Adult T Cell-Depleted Bone Marrow in Fetal Mice

The Journal of immunology (1950), 2002-12, Vol.169 (11), p.6133-6140

2002

Volltextzugriff (PDF)

INCREASED ENGRAFTMENT AND GVHD AFTER IN UTERO TRANSPLANTATION OF MHC-MISMATCHED BONE MARROW CELLS AND CD80low, CD86??? DENDRITIC CELLS IN A FETAL MOUSE MODEL1

Transplantation, 2001-12, Vol.72 (11), p.1768-1776

2001

Volltextzugriff (PDF)

Increased engraftment and GVHD after in utero transplantation of MHC-mismatched bone marrow cells and CD80low, CD86(-) dendritic cells in a fetal mouse model

Transplantation, 2001-12, Vol.72 (11), p.1768

2001

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(11)
Science & Technology
(11)
Female
(8)
Humans
(8)
Hematology
(7)
Male
(7)
Adolescent
(6)
Pediatrics
(5)
Adult
(4)
Child
(4)
Oncology
(4)
Young Adult
(4)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(3)
Animals
(3)
Biological And Medical Sciences
(3)
Child, Preschool
(3)
Medical Sciences
(3)
Middle Aged
(3)
Sickle Cell Disease
(3)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

8 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Physical Therapy in Pediatric and Young Adult Patients With Sickle Cell Disease: Assessing Potential Benefits and Barriers

Direct CNS administration of rituximab and epratuzumab in a pediatric patient with relapsed refractory CNS B‐cell acute lymphoblastic leukemia

Preventing transfusion-transmitted babesiosis: preliminary experience of the first laboratory-based blood donor screening program

Heterogeneity of the long-term economic burden of severe sickle cell disease: a 5-year longitudinal analysis

Lovo-cel (bb1111) Gene Therapy for Sickle Cell Disease: Updated Clinical Results and Investigations into Two Cases of Anemia from Group C of the Phase 1/2 HGB-206 Study

The Grndad Registry: Contemporary Natural History Data and an Analysis of Real-World Patterns of Use and Limitations of Disease Modifying Therapy in Adults with SCD

Efficacy, Safety, and Health-Related Quality of Life (HRQOL) in Patients with Sickle Cell Disease (SCD) Who Have Received Lovotibeglogene Autotemcel (Lovo-cel) Gene Therapy: Up to 60 Months of Follow-up

Severe Acute Complications of Sickle Cell Disease in Two Expert Referral Centers (UK and Italy): Natural History Studies Highlight Ongoing Unmet Need for Effective Disease Modifying or Curative Therapies

Refractory cytopenias secondary to copper deficiency in children receiving exclusive jejunal nutrition

Weight status of children with sickle cell disease

Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States

Real-World Clinical Burden of Sickle Cell Disease in the US Community-Practice Setting: A Single-Center Experience from the Foundation for Sickle Cell Disease Research

Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study

Predictors of Biologic Efficacy with Lovotibeglogene Autotemcel (Lovo-cel) Gene Therapy in Patients with Sickle Cell Disease

Two cases of humoral hypercalcemia of malignancy complicating infantile fibrosarcoma

Transfusion-acquired Trypanosoma cruzi infection

Lovo-cel (bb1111) Gene Therapy for Sickle Cell Disease (SCD): Updated Group C Clinical Results and Investigations into Two Cases of Anemia from the Phase 1/2 HGB-206 Study

381 - Lovo-cel (bb1111) Gene Therapy for Sickle Cell Disease (SCD): Updated Group C Clinical Results and Investigations into Two Cases of Anemia from the Phase 1/2 HGB-206 Study

Efficacy and Safety in Patients (Pts) with Sickle Cell Disease (SCD) Who Have Received Lovotibeglogene Autotemcel (Lovo-cel) Gene Therapy: Up to 60 Months of Follow-up

Outcomes of Immunosuppressive Therapy for Pediatric Aplastic Anemia: A North American Pediatric Aplastic Anemia Consortium (NAPAAC) Study

Prevalence and Complications of Obesity in Sickle Cell Disease

Multilineage Engraftment with Minimal Graft-Versus-Host Disease Following In Utero Transplantation of S-59 Psoralen/Ultraviolet A Light-Treated, Sensitized T Cells and Adult T Cell-Depleted Bone Marrow in Fetal Mice

INCREASED ENGRAFTMENT AND GVHD AFTER IN UTERO TRANSPLANTATION OF MHC-MISMATCHED BONE MARROW CELLS AND CD80low, CD86??? DENDRITIC CELLS IN A FETAL MOUSE MODEL1

Increased engraftment and GVHD after in utero transplantation of MHC-mismatched bone marrow cells and CD80low, CD86(-) dendritic cells in a fetal mouse model

Suchergebnisse filtern